Mukul Agarwal is Vice President at Revance with responsibility for corporate development and strategy, partnering and licensing, and alliance management. He has over 15 years of experience in drug development & commercialization and has led and supported multiple successful M&A, licensing, and JV transactions (both buy and sell side).
Prior to Revance, Mr. Agarwal held the role of Senior Director of Corporate Development and Strategy at Anacor (acquired by Pfizer). He has had roles in BD&L, Global Commercial/Marketing, Finance, and Strategy functions at Forest Pharma (now Allergan), MedImmune (acquired by AZ), GSK and Genentech.
Earlier in his career, Mr. Agarwal was a management consultant with PRTM (now PriceWaterhouse Coopers) for 5 years building their Life Sciences practice. He started as a bench scientist at a start-up. Mr. Agarwal received his M.B.A. from Carnegie Mellon University, M.S. from Ohio State University, and B.S. from Indian Institute of Technology, Delhi.